![Catchet-MS identifies IKZF1-targeting Thalidomide analogues as novel HIV-1 latency reversal agents | bioRxiv Catchet-MS identifies IKZF1-targeting Thalidomide analogues as novel HIV-1 latency reversal agents | bioRxiv](https://www.biorxiv.org/content/biorxiv/early/2021/06/18/2021.03.19.436149/F6.large.jpg)
Catchet-MS identifies IKZF1-targeting Thalidomide analogues as novel HIV-1 latency reversal agents | bioRxiv
![Catchet-MS identifies IKZF1-targeting Thalidomide analogues as novel HIV-1 latency reversal agents | bioRxiv Catchet-MS identifies IKZF1-targeting Thalidomide analogues as novel HIV-1 latency reversal agents | bioRxiv](https://www.biorxiv.org/content/biorxiv/early/2021/06/18/2021.03.19.436149/F7.large.jpg)
Catchet-MS identifies IKZF1-targeting Thalidomide analogues as novel HIV-1 latency reversal agents | bioRxiv
![Catchet-MS identifies IKZF1-targeting Thalidomide analogues as novel HIV-1 latency reversal agents | bioRxiv Catchet-MS identifies IKZF1-targeting Thalidomide analogues as novel HIV-1 latency reversal agents | bioRxiv](https://www.biorxiv.org/content/biorxiv/early/2021/06/18/2021.03.19.436149/F1.large.jpg)
Catchet-MS identifies IKZF1-targeting Thalidomide analogues as novel HIV-1 latency reversal agents | bioRxiv
![Catchet-MS identifies IKZF1-targeting Thalidomide analogues as novel HIV-1 latency reversal agents | bioRxiv Catchet-MS identifies IKZF1-targeting Thalidomide analogues as novel HIV-1 latency reversal agents | bioRxiv](https://www.biorxiv.org/content/biorxiv/early/2021/06/18/2021.03.19.436149/F8.large.jpg)
Catchet-MS identifies IKZF1-targeting Thalidomide analogues as novel HIV-1 latency reversal agents | bioRxiv
Throughput-oriented analytical models for performance estimation on programmable hardware accelerators
![Antibiotics | Free Full-Text | Gatifloxacin Loaded Nano Lipid Carriers for the Management of Bacterial Conjunctivitis Antibiotics | Free Full-Text | Gatifloxacin Loaded Nano Lipid Carriers for the Management of Bacterial Conjunctivitis](https://pub.mdpi-res.com/antibiotics/antibiotics-12-01318/article_deploy/html/images/antibiotics-12-01318-g004.png?1692084887)
Antibiotics | Free Full-Text | Gatifloxacin Loaded Nano Lipid Carriers for the Management of Bacterial Conjunctivitis
![Antibiotics | Free Full-Text | Gatifloxacin Loaded Nano Lipid Carriers for the Management of Bacterial Conjunctivitis Antibiotics | Free Full-Text | Gatifloxacin Loaded Nano Lipid Carriers for the Management of Bacterial Conjunctivitis](https://pub.mdpi-res.com/antibiotics/antibiotics-12-01318/article_deploy/html/images/antibiotics-12-01318-g001-550.jpg?1692084890)
Antibiotics | Free Full-Text | Gatifloxacin Loaded Nano Lipid Carriers for the Management of Bacterial Conjunctivitis
![Catchet-MS identifies IKZF1-targeting Thalidomide analogues as novel HIV-1 latency reversal agents | bioRxiv Catchet-MS identifies IKZF1-targeting Thalidomide analogues as novel HIV-1 latency reversal agents | bioRxiv](https://www.biorxiv.org/content/biorxiv/early/2021/06/18/2021.03.19.436149/F4.large.jpg)
Catchet-MS identifies IKZF1-targeting Thalidomide analogues as novel HIV-1 latency reversal agents | bioRxiv
![Metabolic profiling as a powerful tool for the analysis of cellular alterations caused by 20 mycotoxins in HepG2 cells | Archives of Toxicology Metabolic profiling as a powerful tool for the analysis of cellular alterations caused by 20 mycotoxins in HepG2 cells | Archives of Toxicology](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs00204-022-03348-5/MediaObjects/204_2022_3348_Fig4_HTML.png)
Metabolic profiling as a powerful tool for the analysis of cellular alterations caused by 20 mycotoxins in HepG2 cells | Archives of Toxicology
![Antibiotics | Free Full-Text | Gatifloxacin Loaded Nano Lipid Carriers for the Management of Bacterial Conjunctivitis Antibiotics | Free Full-Text | Gatifloxacin Loaded Nano Lipid Carriers for the Management of Bacterial Conjunctivitis](https://pub.mdpi-res.com/antibiotics/antibiotics-12-01318/article_deploy/html/images/antibiotics-12-01318-g002.png?1692084893)
Antibiotics | Free Full-Text | Gatifloxacin Loaded Nano Lipid Carriers for the Management of Bacterial Conjunctivitis
![Antibiotics | Free Full-Text | Gatifloxacin Loaded Nano Lipid Carriers for the Management of Bacterial Conjunctivitis Antibiotics | Free Full-Text | Gatifloxacin Loaded Nano Lipid Carriers for the Management of Bacterial Conjunctivitis](https://www.mdpi.com/antibiotics/antibiotics-12-01318/article_deploy/html/images/antibiotics-12-01318-g005-550.jpg)